Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Vallecillo, Gabriel
- dc.contributor.author Fonseca Casals, Francina, 1972-
- dc.contributor.author Oviedo, Lina
- dc.contributor.author Duran Jordà, Xavier, 1974-
- dc.contributor.author Martinez, Ignacio
- dc.contributor.author García-Guix, Alexandra
- dc.contributor.author Castillo, Claudio
- dc.contributor.author Torrens, Marta
- dc.contributor.author Llana, Santiago
- dc.contributor.author Roquer, Albert
- dc.contributor.author Martinez, Maria de la Cabeza
- dc.contributor.author Aguelo, Sandra
- dc.contributor.author Canosa, Irene
- dc.contributor.author COSG Group (COVID-19 and Opioids Study Group)
- dc.date.accessioned 2022-09-15T07:15:41Z
- dc.date.available 2022-09-15T07:15:41Z
- dc.date.issued 2022
- dc.description.abstract Introduction: During the COVID-19 pandemic, limited access to health care augmented COVID-19 risk in subjects with opioid use disorder (OUD). The aim of the study was to compare COVID-19 incidence in individuals with OUD receiving continuous clinical care with that of the general population. Methods: A prospective cohort study was carried out from March 2020 to March 2021 comparing COVID-19 cumulative incidence of individuals presenting an OUD receiving integrated clinical care with that of an age-reference general population, in three public outpatient treatment centers for addiction in Barcelona, Spain. Results: Over the study period, 366 individuals received clinical care. Mean age: 48.2±8.9 years, 280 (76.5%) were men and 283 (77.3%) native Spanish. All subjects were on opioid agonist therapy. Prevalence of communicable diseases were: HIV infection in 109 (29.8%) and hepatitis C in 46 (12.6%). Psychiatric comorbidity was present in 207 (56.6%), and 119 (32.5%) had >1 chronic medical disease. Covid-19 was diagnosed in 10 patients: a cumulative incidence of 2,732 casesx100,000 people/year (C.I.95%: 1,318-4,967). There were no differences compared to the age-general population: 2,856 casesx100,000 people/year (C.I.95%: 2,830-2,880) (p=0.81). In the bivariate analysis, hypertension (5[50.0%] vs. 53[14.9%], p=0.01) and cardiovascular chronic diseases (2 [20.0%] vs. 8 [2.2%], p=0.03) were more prevalent in patients with OUD and COVID-19. Conclusions: Individuals with OUD who received integrated clinical care had a COVID-19 incidence comparable to the general population. Ensuring comprehensive healthcare is essential to prevent the clinical impact of COVID-19 on individuals with OUD.
- dc.format.mimetype application/pdf
- dc.identifier.citation Vallecillo G, Fonseca F, Oviedo L, Durán X, Martinez I, García-Guix A, Castillo C, Torrens M, Llana S, Roquer A, Martinez MC, Aguelo S, Canosa I; COSG Group (COVID-19 and Opioids Study Group). Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care. Drug Alcohol Depend Rep. 2022 Mar;2:100027. DOI: 10.1016/j.dadr.2022.100027
- dc.identifier.doi http://dx.doi.org/10.1016/j.dadr.2022.100027
- dc.identifier.issn 2772-7246
- dc.identifier.uri http://hdl.handle.net/10230/54074
- dc.language.iso eng
- dc.publisher Elsevier
- dc.relation.ispartof Drug Alcohol Depend Rep. 2022 Mar;2:100027
- dc.rights © 2022 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.title Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion